“The Vioxx Debacle” illuminates a number of problems in our system of drug testing, approval,
marketing, and clinical application. Dr. Alpert suggests that Merck is unlikely to have “…

I read with interest Mark Wilson’s recent article,“The New England Journal of Medicine:
commercial conflict of interest and revisiting the Vioxx scandal”(1). I believe this is an important …

… withdrawal of its arthritis drug Vioxx following a clinical study … after the recall estimated
that Vioxx caused as many as … flooded with calls from Vioxx patients seeking representation …

… Using the French Mediator and United States' Vioxx drug scandals and infrastructure
disasters as case studies, this article examines and compares debates over class actions, …

… the patients using Vioxx actually required the GI benefit promised by Vioxx but … Redux was
withdrawn, an estimated six million patients took fen-phen.Before and after it withdrew Redux …

… more often in those taking Vioxx than those not taking Vioxx. Vioxx was withdrawn five years
after … events occurred six times more often in those taking Vioxx than those not taking Vioxx. …

The Vioxx drug recall and other cases of withdrawals of approved pharmaceutical products
as a result of reports of serious harm to users indicate that there are many problems …

… nonsteroidal antiinflammatory drugs, the Vioxx Gastrointestinal Outcomes Research (VIGOR) …
He has served as a consultant with attorneys in the Vioxx-related litigation but received no …

… tragedies like Vioxx, Redux, and … , Vioxx, Redux, and many other medications have caused
considerable harm after going on the market. If the cardiovascular problems related to Vioxx …

… A comment on this article appears in" Vioxx redux-or how I learned to worry about
industry-sponsored clinical trials." Indian J Med Ethics. 2016 Oct-Dec; 1 (4): 224-226. …